You're one step closer to unlocking our suite of comprehensive and robust tools.
Fill out the form so we can connect you to the right person.
Recent awards include:
If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at S&P Capital IQ Pro or S&P Capital IQ .
Citius to raise $6M from share offering
S&P Capital IQ Pro | Unrivaled Sector Coverage
S&P Capital IQ Pro | Powering Your Edge
Enterprises are missing out on 24B by not optimizing cloud spending not going multicloud
Investment Research Analysts Providing Greater Coverage on Inflation
Citius Pharmaceuticals, Inc. is looking to raise $6 million from the sale of 1,280,360 common shares at a price of $4.6925 apiece.
The specialty pharmaceutical company will also issue warrants to purchase up to an additional 640,180 shares of the company at $4.63 apiece.
Citius expects to close the offering by Dec. 19.
H.C. Wainwright & Co. is acting as the exclusive placement agent for the offering.
The company will use the net proceeds for general corporate purposes.